Adelaide Research & Scholarship: Search

Search

Results 1-10 of 36 (Search time: 0.002 seconds).

previous
1
2
3
4
next

Item hits:

Preview	Issue Date	Title	Author(s)
	2012	Foleykatheter versus prostaglandine E2-gel voor inleiden van aterme baring	Jozwiak, M.; Oude Rengerink, K.; de Leeuw, J.; Mol, B.; Bloemenkamp, K.; Benthem, M.; van Beek, E.; Dijksterhuis, M.; de Graaf, I.; van Huizen, M.; Oudijk, M.; Papatsonis, D.; Perquin, D.; Porath, M.; van der Post, J.; Rijnders, R.; Scheepers, L.; Spaanderman, M.; van Pampus, M.
	2012	Management of late-preterm premature rupture of membranes: the PPROMEXIL-2 trial	van der Ham, D.; van der Heyden, J.; Opmeer, B.; Mulder, A.; Moonen, R.; van Beek, J.; Franssen, M.; Bloemenkamp, K.; Sikkema, M.; de Groot, C.; Porath, M.; Kwee, A.; Woiski, M.; Duvekot, J.; Akerboom, B.; van Loon, A.; de Leeuw, J.; Willekes, C.; Mol, B.; Nijhuis, J.
	2014	Cost-effectiveness analysis of cardiovascular risk factor screening in women who experienced hypertensive pregnancy disorders at term	Van Baaren, G.; Hermes, W.; Franx, A.; Van Pampus, M.; Bloemenkamp, K.; Van Der Post, J.; Porath, M.; Ponjee, G.; Tamsma, J.; Mol, B.; Opmeer, B.; De Groot, C.
	2011	Preventing preterm birth with progesterone: costs and effects of screening low risk women with a singleton pregnancy for short cervical length, the Triple P study	van Os, M.; van der Ven, J.; Kleinrouweler, C.; Pajkrt, E.; de Miranda, E.; van Wassenaer, A.; Porath, M.; Bossuyt, P.; Bloemenkamp, K.; Willekes, C.; Woiski, M.; Oudijk, M.; Bilardo, K.; Sikkema, M.; Duvekot, J.; Veersema, D.; Laudy, J.; Kuiper, P.; de Groot, C.; Mol, B.; et al.
	2013	Cardiovascular risk estimation in women with a history of hypertensive pregnancy disorders at term: a longitudinal follow-up study	Hermes, W.; Tamsma, J.; Grootendorst, D.; Franx, A.; van der Post, J.; van Pampus, M.; Bloemenkamp, K.; Porath, M.; Mol, B.; de Groot, C.
	2014	Using vaginal Group B Streptococcus colonisation in women with preterm premature rupture of membranes to guide the decision for immediate delivery: a secondary analysis of the PPROMEXIL trials	Tajik, P.; van der Ham, D.; Zafarmand, M.; Hof, M.; Morris, J.; Franssen, M.; de Groot, C.; Duvekot, J.; Oudijk, M.; Willekes, C.; Bloemenkamp, K.; Porath, M.; Woiski, M.; Akerboom, B.; Sikkema, J.; Bijvank, B.; Mulder, A.; Bossuyt, P.; Mol, B.
	2014	Rapid target allopurinol concentrations in the hypoxic fetus after maternal administration during labour	Kaandorp, J.; van Den Broek, M.; Benders, M.; Oudijk, M.; Porath, M.; Oetomo, S.; Wouters, M.; van Elburg, R.; Franssen, M.; Bos, A.; Mol, B.; Visser, G.; van Bel, F.; Rademaker, C.; Derks, J.; De Haan, T.; Boon, J.; De Boer, I.; Rijnders, R.; Jacobs, C.; et al.
	2012	Remifentanil patient controlled analgesia versus epidural analgesia in labour. A multicentre randomized controlled trial	Freeman, L.; Bloemenkamp, K.; Franssen, M.; Papatsonis, D.; Hajenius, P.; van Huizen, M.; Bremer, H.; Van den Akker, E.; Woiski, M.; Porath, M.; van Beek, E.; Schuitemaker, N.; van der Salm, P.; Fong, B.; Radder, C.; Bax, C.; Sikkema, M.; van den Akker-van Marle, M.; van Lith, J.; Lopriore, E.; et al.
	2013	Correction: Induction of labour versus expectant monitoring for gestational hypertension or mild pre-eclampsia between 34 and 37 weeks' gestation (HYPITAT-II): a multicentre, open-label randomised controlled trial	Broekhuijsen, K.; Langenveld, J.; van Baaren, G.J.; van Pampus, M.G.; van Kaam, A.H.; Groen, H.; Porath, M.; Franssen, M.T.M.; Mol, B.W.; HYPITAT-II study group,
	2016	Nifedipine versus atosiban for threatened preterm birth (APOSTEL III): a multicentre, randomised controlled trial	Van Vliet, E.; Nijman, T.; Schuit, E.; Heida, K.; Opmeer, B.; Kok, M.; Gyselaers, W.; Porath, M.; Woiski, M.; Bax, C.; Bloemenkamp, K.; Scheepers, H.; Jacquemyn, Y.; Beek, E.; Duvekot, J.; Franssen, M.; Papatsonis, D.; Kok, J.; Van Der Post, J.; Franx, A.; et al.